Literature DB >> 687507

Disopyramide pharmacokinetics and bioavailability.

D K Dubetz, N N Brown, W D Hooper, M J Eadie, J H Tyrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687507      PMCID: PMC1429451          DOI: 10.1111/j.1365-2125.1978.tb04598.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.

Authors:  T C Hutsell; S J Stachelski
Journal:  J Chromatogr       Date:  1975-03-19

2.  Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Authors:  P H Hinderling; E R Garrett
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

3.  Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.

Authors:  R E Ranney; R R Dean; A Karim; F M Radzialowski
Journal:  Arch Int Pharmacodyn Ther       Date:  1971-05

4.  Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues.

Authors:  R J Jaeger; R J Rubin
Journal:  N Engl J Med       Date:  1972-11-30       Impact factor: 91.245

5.  Migration of plasticizer from hemodialysis blood tubing. Preliminary report.

Authors:  K Ono; R Tatsukawa; T Wakimoto
Journal:  JAMA       Date:  1975-12-01       Impact factor: 56.272

  5 in total
  5 in total

Review 1.  Clinical pharmacokinetics of disopyramide.

Authors:  A Karim; C Nissen; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

Review 2.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of disopyramide.

Authors:  L A Siddoway; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 4.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

5.  The impact of neglecting nonlinear plasma-protein binding on disopyramide bioavailability studies.

Authors:  R A Upton; R L Williams
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.